Marcy l'Etoile, France - April 23, 2009.
- Up 6.4% - At constant exchange rates and scope of consolidation.
- Up 10.6% - At constant exchange rates, including business development agreements.
bioMérieux, a global leader in the field of in vitro diagnostics, released its quarterly business review through March 31, 2009. As of March 31, 2009, net sales amounted to €286 million, up 6.4% at constant exchange rates and scope of consolidation (on a like-for-like basis) versus the first quarter of 2008. Factoring in sales related to business development agreements, the increase was 10.6% at constant exchange rates.
Download
- Filename
- pr_biomerieux_2009_q1_sales_en.pdf
- Size
- 39 KB
- Format
- application/pdf